
Sunesis Pharmaceuticals (SNSS)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Sunesis Pharmaceuticals (SNSS) Stock
Start investing in Sunesis Pharmaceuticals (SNSS)
About Sunesis Pharmaceuticals (SNSS)
Market cap | $437.2K |
Today's volume | — |
Revenue (TTM) | — |
Avg. daily volume | 116.2K |
EBITDA (TTM) | -$46.07M |
Open | — |
Price / earnings ratio | -0.01x |
Today's range | — |
Debt / equity | — |
52 week range | $0.01 - $0.58 |
5 year debt / equity | — |
Beta (LTM) | 0.62x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 0.76x |
Ex-dividend date | — |
Next earnings | Nov 16, 2020 |
Dividend payable date | — |
Sunesis Pharmaceuticals Stock News
View all



Frequently Asked Questions (FAQ)
How to buy SNSS stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in SNSS stock
Navigate to the Explore page. Then, type SNSS into the search bar. When you see SNSS stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased SNSS stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Sunesis Pharmaceuticals Stock Earnings
The value each SNSS share was expected to gain vs. the value that each SNSS share actually gained.
Sunesis Pharmaceuticals (SNSS) reported Q3 2020 earnings per share (EPS) of -$0.29, beating estimates of -$0.34 by 14.71%. In the same quarter last year, Sunesis Pharmaceuticals's earnings per share (EPS) was $0. Sunesis Pharmaceuticals is expected to release next earnings on 11/16/2020, with an earnings per share (EPS) estimate of $0.